Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Crossover Study to Assess the Effects of Nicotinamide Riboside on Cognitive Function, Mood and Sleep in Older Adult Men and Women
Conditions
Interventions
300 mg/day of TRU NIAGEN (nicotinamide riboside)
1000 mg/day of TRU NIAGEN (nicotinamide riboside)
+1 more
Locations
1
United States
MB Clinical Research
Boca Raton, Florida, United States
Start Date
June 13, 2018
Primary Completion Date
April 26, 2019
Completion Date
April 26, 2019
Last Updated
July 24, 2019
NCT01778504
NCT06430957
NCT07482930
NCT07477236
NCT07476053
NCT07292922
Lead Sponsor
ChromaDex, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions